Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

Abstract Background Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes. The aims of this study are to determine whether lansoprazole imp...

Full description

Bibliographic Details
Published in:Diabetology & Metabolic Syndrome
Main Authors: Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun
Format: Article
Language:English
Published: BMC 2023-05-01
Subjects:
Cohort studies
Lansoprazole
Proton pump inhibitors
Type
2 diabetes mellitus
Online Access:https://doi.org/10.1186/s13098-023-01051-8

Internet

https://doi.org/10.1186/s13098-023-01051-8

Similar Items